Title:Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer’s and Parkinson’s Diseases
Volume: 10
Issue: 3
Author(s): Jordan A. McKenzie, Lindsay J. Spielman, Caitlin B. Pointer, Jessica R. Lowry, Ekta Bajwa, Carolyn W. Lee and Andis Klegeris*
Affiliation:
- Department of Biology, The Irving K. Barber School of Arts and Sciences, University of British Columbia Okanagan Campus, Kelowna, BC,Canada
Keywords:
Physical inactivity, type 2 diabetes mellitus, obesity, hypertension, microglia, dementia.
Abstract: Background: Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) are among the
most common causes of dementia, which increasingly contribute to morbidity and mortality worldwide.
A common hallmark in the pathogenesis of these two diseases is neuroinflammation, which is
initially triggered by the presence of pathological structures associated with these disorders. Chronic
neuroinflammation is sustained by persistent and aberrant microglial activation in the brain, which
results in damage and death of neighboring cells, including neurons and glial cells. Two types of
risk factors contribute to the development of AD and PD: non-modifiable risk factors and modifiable
risk factors. Non-modifiable risk factors include genetic susceptibility that increases an individual’s
risk of developing the disease, whereas modifiable risk factors include a wide variety of
health- and lifestyle-related factors that may be altered by changing individual behaviors.
Method: Ovid Medline and PubMed databases were used to perform an ordered search of the peerreviewed
research literature described in this review.
Results: This review focuses on four modifiable risk factors including physical inactivity, vascular
disease-related conditions, obesity and type two diabetes mellitus, all of which have been identified
as risk factors for the development of AD and PD.
Conclusion: We highlight that control of the modifiable risk factors is a valid approach for managing
the increased incidence of AD and PD. We describe neuroinflammatory mechanisms, which are
common to AD and PD that may link both these neurodegenerative diseases with the four common
modifiable risk factors. Understanding neuroinflammatory mechanisms could help identify novel
therapeutic targets for combating these neurodegenerative diseases.
